Free Shipping on purchases over €100

Comforsil Bunion Night Corrector Cc250/1/2, Left Side

Night splint to position the 1st toe correctly, relieving pain during the night by relaxing the abductor tendon causing the deformity of the big toe.

SKU: 163003
-13%
Promo FD
9.50
€10.92

Pharmaceutical Care

Safe medication sales

Secure shipping

INFO AND TECHNICAL SPECIFICATIONS

The Comforsil nighttime bunion corrector is a splint designed to be used at night to help realign the bone of the left toe. To take advantage of its benefits, it is essential to use it continuously every night. The treatment consists of rehabilitating this part of the foot to promote a healthy posture.

During this process, the joint that has been forced to become exaggeratedly enlarged is gently pressed by the splint and the surrounding band. This helps to soothe the pain and helps the joint to gradually return to its original shape. The Velcro strap makes it easy to adjust, a feature that also helps to accelerate the success of the treatment.

It helps the bone to find its original shape, helping to reduce the protrusion that causes pain. In addition, the splint is long to prevent the malformation from moving to another side of the toe or foot. Hence the importance of its size, which has the function of keeping the toe in the proper posture.

At one end of the splint there is a Velcro strap to adjust it to the foot. In this way, the bunion corrector will begin its work to help relieve pain and help realign the bones of the left toe.

Tecnical specifications card

Pharmaceutical advice

You can now consult our team with any questions you may have. We remind you that our chatbot is also available for simpler queries.

Ask us
  • Vendor: Tecnosoluciones Médicas
  • Vendor address: Calle Mar Mediterrania (Polígono Industrial Torre del Rector), 5-9, 08130 Santa Perpètua de Mogoda, Barcelona, España
  • Phone number: +34 935 747 440
Newsletter

Don’t miss anything

Stay up to date with the latest advances in health, discounts, and pharmaceutical news.